Tobramycin, 0.3%, 5mL (Somerset Therapeutics)


THIS WEBSITE IS FOR DOCTORS ONLY. TO VISIT OUR RETAIL STORE CLICK HERE

Description

NDC: 70069-131-01

Tobramycin 0.3% Ophthalmic Solution, 5 mL — Somerset Therapeutics

Active ingredients Tobramycin 0.3% (3 mg/mL)
Dosage form Ophthalmic solution
Route Topical ophthalmic
Size 5 mL
Manufacturer Somerset Therapeutics
NDC 70069-131-01

Indications and Usage

A topical antibiotic indicated for the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. It has been shown to be safe and effective in pediatric patients.

Dosage and Administration

For mild to moderate disease, instill one or two drops into the affected eye(s) every four hours. In severe infections, instill two drops into the eye(s) hourly until improvement, after which treatment should be reduced prior to discontinuation.

Warnings and Precautions

  • For topical ophthalmic use only; not for injection into the eye
  • Sensitivity reactions may occur, ranging from local irritation to systemic hypersensitivity
  • Prolonged use may result in overgrowth of nonsusceptible organisms, including fungi
  • Do not wear contact lenses during treatment of an ocular infection

Contraindications

Contraindicated in patients with known hypersensitivity to tobramycin or any component of the product.

Adverse Reactions

The most frequent adverse reactions are localized ocular toxicity and hypersensitivity, including lid itching and swelling and conjunctival erythema, occurring in less than 3% of patients. Postmarketing reports include anaphylaxis, Stevens-Johnson syndrome, and erythema multiforme.

Storage and Handling

Store at 2°C to 25°C (36°F to 77°F). The product may be used until the expiration date on the container.

How Supplied

Supplied as a sterile ophthalmic solution, 5 mL fill in a white opaque LDPE bottle with a dropper tip and tamper-evident closure.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

You may also like

Recently viewed